The study of disease has been hampered by a lack of in vitro models that correlate with clinical data. Researchers have traditionally relied on animal or tumor-derived cells, lines immortalized through genetic modification, or difficult to obtain primary tissue. The advent of iPS cells has drastically changed the field by providing a simple platform to study a wide range of human diseases and to screen novel drugs to treat them. Read more about the advantages of iPSC-derived disease models.
Trust our team to support your research.